X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-10-06 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $3.16 | -227 | 58,253 | 0% | -$717 | ||||||
2025-10-02 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $22.58 | -1,339 | 325,699 | 0% | -$30,235 | ||||||
2025-10-02 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $64.00 | -9,692 | 478,182 | -2% | -$620,312 | ||||||
2025-10-01 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $35.00 | -2,539 | 89,099 | -3% | -$88,865 | ||||||
| D | 2025-10-01 | VCYT | Veracyte, Inc. | Epstein Robert S | Dir | S - Sale+OE | $35.08 | -21,473 | 62,446 | -26% | -$753,204 | |||||
2025-10-01 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $35.00 | -2,160 | 89,439 | -2% | -$75,608 | ||||||
2025-10-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $159.99 | -3,000 | 117,559 | -2% | -$479,969 | ||||||
| D | 2025-09-30 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $162.05 | -1,364 | 203,300 | -1% | -$221,040 | |||||
| DM | 2025-09-30 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $160.80 | -23,192 | 154,072 | -13% | -$3,729,372 | |||||
| D | 2025-09-30 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $162.05 | -2,491 | 69,189 | -3% | -$403,674 | |||||
| D | 2025-09-26 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale+OE | $188.13 | -227 | 43,809 | -1% | -$42,706 | |||||
| DM | 2025-09-23 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale+OE | $187.12 | -28,463 | 43,808 | -39% | -$5,326,042 | |||||
2025-09-19 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $33.69 | -2,283 | 91,599 | -2% | -$76,920 | ||||||
2025-09-19 | BDSX | Biodesix Inc | Schuler Jack W | Dir, 10% | P - Purchase | $7.04 | +142,045 | 2,130,745 | +7% | +$999,997 | ||||||
| M | 2025-09-17 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $178.70 | -14,070 | 296,746 | -5% | -$2,514,354 | |||||
| M | 2025-09-18 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $180.33 | -50,000 | 2,335,852 | -2% | -$9,016,668 | |||||
2025-09-17 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $21.97 | -1,339 | 327,038 | 0% | -$29,419 | ||||||
| M | 2025-09-17 | BDSX | Biodesix Inc | Schuler Jack W | Dir, 10% | P - Purchase | $6.06 | +18,373 | 1,988,700 | +1% | +$111,425 | |||||
2025-09-16 | RDNT | Radnet, Inc. | Stolper Mark | EVP, CFO | S - Sale | $73.89 | -35,000 | 68,012 | -34% | -$2,586,150 | ||||||
| D | 2025-09-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale+OE | $55.63 | -116 | 7,591 | -2% | -$6,453 | |||||
| D | 2025-09-17 | GH | Guardant Health, Inc. | Potter Myrtle S | Dir | S - Sale+OE | $55.63 | -26 | 18,281 | 0% | -$1,446 | |||||
| D | 2025-09-16 | FTRE | Fortrea Holdings Inc. | Parks Robert | Chief Accounting Officer | S - Sale+OE | $9.95 | -7,338 | 19,046 | -28% | -$73,013 | |||||
2025-09-16 | RDNT | Radnet, Inc. | Katz David Jeffrey | EVP, GC | S - Sale | $74.44 | -14,000 | 68,181 | -17% | -$1,042,160 | ||||||
2025-09-12 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $170.54 | -5,000 | 2,385,852 | 0% | -$852,707 | ||||||
2025-09-12 | GH | Guardant Health, Inc. | Hidalgo Medina Manuel | Dir | S - Sale | $54.16 | -2,165 | 851 | -72% | -$117,251 | ||||||
2025-09-11 | RDNT | Radnet, Inc. | Wesdorp Cornelis | Pres, CEO, Digital Health | S - Sale | $72.13 | -500 | 53,495 | -1% | -$36,065 | ||||||
2025-09-10 | RDNT | Radnet, Inc. | Hames Norman R | Pres, COO-West Operations | S - Sale | $72.74 | -10,000 | 239,183 | -4% | -$727,400 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $3.13 | -3,246 | 807,890 | 0% | -$10,160 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $3.13 | -1,271 | 175,669 | -1% | -$3,978 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $3.13 | -934 | 126,817 | -1% | -$2,923 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $3.13 | -645 | 99,932 | -1% | -$2,019 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $3.13 | -1,395 | 159,493 | -1% | -$4,366 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $3.13 | -915 | 284,670 | 0% | -$2,864 | ||||||
2025-09-09 | GH | Guardant Health, Inc. | Eltoukhy Helmy | Co-CEO | S - Sale | $59.45 | -300,000 | 2,123,499 | -12% | -$17,835,995 | ||||||
| A | 2025-09-09 | SERA | Sera Prognostics, Inc. | Lawrence Sandra Aj | Dir | S - Sale | $3.05 | -1,560 | 21,153 | -7% | -$4,758 | |||||
| D | 2025-09-09 | FTRE | Fortrea Holdings Inc. | Parks Robert | Chief Accounting Officer | S - Sale+OE | $10.23 | -592 | 1,450 | -29% | -$6,056 | |||||
| D | 2025-09-09 | FTRE | Fortrea Holdings Inc. | Hanson James S. | GC | S - Sale+OE | $10.23 | -1,677 | 19,092 | -8% | -$17,156 | |||||
| D | 2025-09-09 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $10.23 | -3,155 | 61,601 | -5% | -$32,276 | |||||
| D | 2025-09-09 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $10.23 | -3,156 | 58,770 | -5% | -$32,286 | |||||
2025-09-09 | RDNT | Radnet, Inc. | Wesdorp Cornelis | Pres, CEO, Digital Health | S - Sale | $71.99 | -500 | 53,995 | -1% | -$35,995 | ||||||
2025-09-08 | CELC | Celcuity Inc. | Baker Bros. Advisors LP | 10% | P - Purchase | $56.27 | +170,100 | 7,211,484 | +2% | +$9,571,319 | ||||||
2025-09-09 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $3.15 | -21,158 | 811,136 | -3% | -$66,648 | ||||||
2025-09-09 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $3.15 | -5,263 | 285,585 | -2% | -$16,578 | ||||||
2025-09-09 | SERA | Sera Prognostics, Inc. | Lawrence Sandra Aj | Dir | S - Sale | $3.05 | -3,899 | 18,814 | -17% | -$11,892 | ||||||
2025-09-09 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $3.05 | -2,000 | 100,577 | -2% | -$6,100 | ||||||
2025-09-04 | VCYT | Veracyte, Inc. | Stapley Marc | CEO | S - Sale | $30.41 | -7,667 | 334,185 | -2% | -$233,133 | ||||||
2025-09-02 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $166.53 | -5,079 | 158,514 | -3% | -$845,795 | ||||||
2025-09-02 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $166.62 | -3,000 | 120,859 | -2% | -$499,865 | ||||||
2025-09-05 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $3.35 | -222 | 58,480 | 0% | -$744 | ||||||
2025-09-02 | XGN | Exagen Inc. | Black Jeffrey G. | CFO | S - Sale | $9.79 | -20,466 | 269,026 | -7% | -$200,362 | ||||||
2025-09-02 | FTRE | Fortrea Holdings Inc. | Russell Erin L | Dir | P - Purchase | $10.15 | +9,854 | 9,854 | New | +$100,018 | ||||||
2025-09-02 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $23.93 | -1,339 | 328,377 | 0% | -$32,042 | ||||||
2025-09-02 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale | $65.84 | -100 | 11,183 | -1% | -$6,584 | ||||||
2025-09-03 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $22.03 | -1,063 | 957,085 | 0% | -$23,414 | ||||||
2025-09-03 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $22.03 | -1,128 | 584,937 | 0% | -$24,846 | ||||||
2025-08-29 | BDSX | Biodesix Inc | Schuler Jack W | Dir, 10% | P - Purchase | $0.43 | +3,488,372 | 39,406,546 | +10% | +$1,500,000 | ||||||
2025-09-02 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $3.49 | -1,458 | 176,940 | -1% | -$5,088 | ||||||
2025-08-28 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $166.99 | -2,750 | 6,015 | -31% | -$459,223 | ||||||
2025-08-29 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $3.49 | -10,542 | 178,398 | -6% | -$36,792 | ||||||
2025-08-27 | RDNT | Radnet, Inc. | Hames Norman R | Pres, COO-West Operations | S - Sale | $71.10 | -5,000 | 19,889 | -20% | -$355,500 | ||||||
2025-08-27 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $22.02 | -12,677 | 141,116 | -8% | -$279,135 | ||||||
2025-08-27 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $21.69 | -18,007 | 153,793 | -10% | -$390,572 | ||||||
2025-08-27 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $21.48 | -1,199 | 586,065 | 0% | -$25,760 | ||||||
2025-08-27 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $21.48 | -943 | 958,148 | 0% | -$20,260 | ||||||
2025-08-25 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $21.50 | -696 | 587,264 | 0% | -$14,965 | ||||||
2025-08-25 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $21.50 | -548 | 959,091 | 0% | -$11,783 | ||||||
2025-08-21 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | S - Sale | $185.00 | -1,975 | 15,269 | -11% | -$365,375 | ||||||
2025-08-21 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale | $61.76 | -2,000 | 18,500 | -10% | -$123,510 | ||||||
| D | 2025-08-19 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | S - Sale+OE | $183.00 | -4,532 | 17,244 | -21% | -$829,356 | |||||
2025-08-19 | RDNT | Radnet, Inc. | Wesdorp Cornelis | Pres, CEO, Digital Health | S - Sale | $66.98 | -1,500 | 54,495 | -3% | -$100,470 | ||||||
2025-08-19 | RDNT | Radnet, Inc. | Jayanathan Ranjan | CIO | S - Sale | $67.50 | -65,598 | 138,198 | -32% | -$4,427,865 | ||||||
2025-08-19 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $59.02 | -116 | 7,458 | -2% | -$6,846 | ||||||
2025-08-19 | GH | Guardant Health, Inc. | Potter Myrtle S | Dir | S - Sale | $59.02 | -26 | 18,239 | 0% | -$1,535 | ||||||
2025-08-20 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $2.22 | -6,000 | 102,577 | -6% | -$13,320 | ||||||
| D | 2025-08-19 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $8.01 | -4,886 | 57,600 | -8% | -$39,137 | |||||
| D | 2025-08-19 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $8.01 | -4,886 | 54,770 | -8% | -$39,137 | |||||
2025-08-19 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $32.02 | -4,202 | 487,874 | -1% | -$134,548 | ||||||
2025-08-19 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $32.02 | -877 | 285,143 | 0% | -$28,082 | ||||||
2025-08-15 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | S - Sale | $180.00 | -1,975 | 17,244 | -10% | -$355,500 | ||||||
2025-08-15 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.04 | -1,339 | 329,716 | 0% | -$26,834 | ||||||
2025-08-14 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $155.46 | -875 | 123,859 | -1% | -$136,027 | ||||||
2025-08-14 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $155.46 | -678 | 152,747 | 0% | -$105,401 | ||||||
2025-08-13 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $19.50 | -43,019 | 331,055 | -12% | -$839,043 | ||||||
| D | 2025-08-13 | LH | Labcorp Holdings Inc. | Van Der Vaart Sandra D | EVP, GC | S - Sale+OE | $271.43 | -3,903 | 2,274 | -63% | -$1,059,371 | |||||
2025-08-13 | RDNT | Radnet, Inc. | Katz David Jeffrey | EVP, GC | S - Sale | $68.31 | -17,000 | 86,774 | -16% | -$1,161,270 | ||||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $0.42 | -988 | 250,794 | 0% | -$411 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $0.42 | -3,772 | 728,824 | -1% | -$1,570 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $0.42 | -476 | 140,065 | 0% | -$198 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $0.42 | -442 | 157,878 | 0% | -$184 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $0.42 | -228 | 18,375 | -1% | -$95 | |||||
2025-08-13 | EXAS | Exact Sciences Corp | Doyle James Edward | Dir | S - Sale | $42.02 | -1,485 | 59,962 | -2% | -$62,400 | ||||||
2025-08-11 | LH | Labcorp Holdings Inc. | Schechter Adam H | Pres, CEO | S - Sale | $266.78 | -5,643 | 93,319 | -6% | -$1,505,440 | ||||||
| M | 2025-08-08 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $157.84 | -6,070 | 310,816 | -2% | -$958,059 | |||||
| M | 2025-08-08 | FTRE | Fortrea Holdings Inc. | Neupert Peter M | Dir | P - Purchase | $6.51 | +62,500 | 98,132 | +175% | +$407,150 | |||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $2.54 | -8,571 | 832,294 | -1% | -$21,770 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $2.54 | -6,460 | 188,940 | -3% | -$16,408 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $2.54 | -6,447 | 127,751 | -5% | -$16,375 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $2.54 | -5,962 | 108,577 | -5% | -$15,143 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $2.54 | -7,094 | 160,888 | -4% | -$18,019 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $2.54 | -5,800 | 290,848 | -2% | -$14,732 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |